Alternatives to Mileutis

AI-driven digital twin of embryo development for cell-based therapies.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

Biopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Biopharmaceutical startup developing novel therapies for rare genetic diseases.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

Omnix Medical is developing a novel platform for advanced wound care management.

Develops a platform for individual drug customization using aptamers for cancer treatment.

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.

Compressing biology to develop the next generation of therapies.

AI-powered insights platform for life sciences and biotech workflows.

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.

Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.

Omec.ai is a life sciences startup focused on accelerating drug discovery and development through AI.

Biotech developing novel technologies to restore physiological balance in apoptosis-related diseases.

Developing a novel small molecule inhibitor for ovarian cancer treatment targeting DIO3.

Clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers.

Develops and launches Padeliporfin VTP therapy for solid tumor treatment.